Niels Vande Casteele, PharmD, PhD

University of California San Diego

Poster(s):

• P2221 - Benefit-Risk Analysis of Point of Care Therapeutic Drug Monitoring vs Empiric Dose Escalation in Patients with Secondary Loss of Response to Infliximab
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT